Board of Directors Member
Lobular Breast Cancer Alliance
LBCA seeks board members who will champion LBCA’s mission, who may have been directly impacted by ILC, and who are deeply caring and will be dedicated to promoting and helping LBCA fund ILC research. We believe that serving on our Board of Directors will be an extraordinary opportunity to be part of something great that will help change the future for women diagnosed with lobular breast cancer. Our expectations of LBCA Board of Directors are as follows.
- Make the Lobular Breast Cancer Alliance a top priority.
- Serve actively.
- Prepare for and attend and conscientiously participate in monthly two-hour Board meetings virtually and one in-person meeting/year, and be available for phone consultation outside of meetings.
- Participate in one or more committees that may arise.
- Contribute individual expertise and knowledge in the deliberations of the Board and act as a resource for staff when called upon.
- Be an ambassador and advocate for the Lobular Breast Cancer Alliance.
- Understand and articulate LBCA’s mission, vision and goals of the organization.
- Show support for LBCA’s policies and decisions.
- Engage, as needed with LBCA’s volunteer network - including advocates and scientific advisors - by participating when possible in volunteer-driven events.
- Engage actively in meeting the LBCA’s financial goals.
- Assist in the cultivation of prospective donors and sponsors including attending special events as a representative of the Board.
- Facilitate financial opportunities and other productive relationships for the organization.
- Have the financial acumen to read and understand LBCA’s financial statements and to otherwise help the board fulfill its fiduciary responsibilities.
- Make a personally meaningful financial contribution(s) to the organization each year without being asked.
- Other expectations
- Follow LBCA’s bylaws, policies, and board resolutions.
- Sign an annual conflict-of-interest disclosure and update it during the year if necessary, as well as disclose potential conflicts before meetings and actual conflicts during meetings.
- Maintain confidentiality about all internal matters.
- Directors are expected to serve a three year term and may serve up to two consecutive three year terms before a requisite one year break.
Desired Skills and Expertise
The ideal board candidate should have prior nonprofit board member experience and will provide a resume that highlights former board member activity and employment history. Interested applicants should be prepared to provide two character and two work-related references.
No additional volunteer opportunities at this time.
About Lobular Breast Cancer Alliance
23564 Calabasas Road, Suite 201, Calabasas, CA 91302, US
As the only organization in the US dedicated to Invasive Lobular Breast Cancer (ILC), LBCA’s mission is: to make all who are touched by ILC aware of its unique characteristics and the critical need for more ILC research, to be the go-to source for information on ILC studies, clinical trials and educational tools, to foster partnerships among patients, scientists, clinicians and breast cancer organizations to increase dialogue about ILC and research advocacy, and to fund vital ILC research. LBCA’s Vision is a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently.
LBCA engages patients, clinicians, and researchers to increase knowledge of lobular breast disease and promote lobular breast cancer research. Working with the guidance of an international, expert scientific advisory board of 14 breast cancer researchers and clinicians, and through growing collaborations with other breast cancer advocacy organizations in the US and internationally, LBCA provides a platform for ILC research, maintains a library of current lobular breast cancer studies, and identifies clinical trials and research advocacy opportunities with a focus on lobular breast disease. LBCA provides and disseminates widely basic, current educational information about ILC including early stage and metastatic lobular breast cancer, to enhance understanding about how lobular is different from other breast cancer sub-types, and share any new knowledge gleaned from recent research.